New strides in medical marijuana treatments.
Advisors to the FDA have found a generally favorable benefit-risk profile for cannabidiol oil as a solution in the treatment of two forms of severe pediatric seizure disorders.
"In a unanimous vote, the 13 members of the FDA’s Peripheral and Central Nervous System Drugs
found that the benefit-risk profile of cannabidiol is favorable for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS) in patients 2 years of age and older."
If the FDA decides to support the recommendation cannabidiol oral solution would be the first cannabis-based medication approved in the U.S.
"Patients with LGS taking cannabidiol oral solution at 20 mg/kg/day in two clinical trials saw ain drop seizure frequency over a 14-week treatment period (P = .0047 and P = .0135, compared to placebo). A 50% reduction of drop seizure frequency was seen in 40% and 44% of LGS patients in the two clinical trials.For patients with DS, 20 mg/kg/day of cannabidiol oral solution resulted in a in convulsive seizure frequency during a 14-week treatment period (P less than .05). There was a numeric, but not statistically significant, increase in the number of DS patients who saw a 50% reduction in convulsive seizure frequency on this dose."
CBD oil is a derivative of the cannabis plant and it is administered orally or as a topical oil. The reduction or elimination of seizures paves way for treatment of patients with severe epilepsy.
With New York's newly legalized medicinal marijuana program, patients suffering with seizures and epilepsy can have access to this medicine.
Each new study illustrates more about the amazing benefits this plant has to offer to patients.
Medical marijuana is no longer out of reach for any New Yorker. Cannabis has healing properties including analgesic, anti-emetic, anti-oxidative, anti- inflammatory and modulation of glial cells and tumor growth.
If you feel as though you would benefit from it's use, Dr. Enzenbacher is licensed and certified for medical marijuana consults. Call (914) 325-1664 to schedule your consult.
Oakes, K. (2018, April 19). FDA panel recommends CBD for pediatric seizure disorders. Retrieved April 19, 2018, from https://www.mdedge.com/clinicalneurologynews/article/163796/epilepsy-seizures/fda-panel-recommends-cbd-pediatric-seizure?channel=211&utm_source=News_CNN_br_041918_F&utm_medium=email&utm_content=BREAKING NEWS: FDA panel recommends cannabinoid for pediatric seizure disorders